SK143199A3 - Pharmaceutical composition for treating sleep apnea, lung alveolar surfactant, phospholipid, use thereof and device for treating sleep apnea - Google Patents

Pharmaceutical composition for treating sleep apnea, lung alveolar surfactant, phospholipid, use thereof and device for treating sleep apnea Download PDF

Info

Publication number
SK143199A3
SK143199A3 SK1431-99A SK143199A SK143199A3 SK 143199 A3 SK143199 A3 SK 143199A3 SK 143199 A SK143199 A SK 143199A SK 143199 A3 SK143199 A3 SK 143199A3
Authority
SK
Slovakia
Prior art keywords
sleep apnea
surfactant
phospholipid
treating sleep
apnea
Prior art date
Application number
SK1431-99A
Other languages
English (en)
Slovak (sk)
Inventor
Keith C Meyer
Safwan M Badr
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of SK143199A3 publication Critical patent/SK143199A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1431-99A 1997-04-16 1998-04-16 Pharmaceutical composition for treating sleep apnea, lung alveolar surfactant, phospholipid, use thereof and device for treating sleep apnea SK143199A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/834,369 US5958902A (en) 1997-04-16 1997-04-16 Method and composition for treating sleep apnea
PCT/US1998/007735 WO1998046245A1 (en) 1997-04-16 1998-04-16 Method and composition for treating sleep apnea

Publications (1)

Publication Number Publication Date
SK143199A3 true SK143199A3 (en) 2001-01-18

Family

ID=25266775

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1431-99A SK143199A3 (en) 1997-04-16 1998-04-16 Pharmaceutical composition for treating sleep apnea, lung alveolar surfactant, phospholipid, use thereof and device for treating sleep apnea

Country Status (24)

Country Link
US (3) US5958902A (bg)
EP (1) EP1009411B1 (bg)
JP (1) JP2001507364A (bg)
KR (1) KR100381643B1 (bg)
CN (1) CN1252727A (bg)
AR (1) AR012221A1 (bg)
AT (1) ATE298241T1 (bg)
AU (1) AU722866B2 (bg)
BG (1) BG103800A (bg)
BR (1) BR9809090A (bg)
CA (1) CA2285574C (bg)
CO (1) CO4940399A1 (bg)
DE (1) DE69830660T2 (bg)
HK (1) HK1026141A1 (bg)
HU (1) HUP0002645A3 (bg)
ID (1) ID29298A (bg)
IL (2) IL132133A0 (bg)
NO (1) NO994613L (bg)
NZ (1) NZ337969A (bg)
PL (1) PL336326A1 (bg)
SK (1) SK143199A3 (bg)
TR (1) TR199902577T2 (bg)
TW (1) TWI221771B (bg)
WO (1) WO1998046245A1 (bg)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6641542B2 (en) * 2001-04-30 2003-11-04 Medtronic, Inc. Method and apparatus to detect and treat sleep respiratory events
US20060057227A1 (en) * 2002-02-15 2006-03-16 Fisher Jeffrey J Throat spray
US7879358B2 (en) 2002-03-20 2011-02-01 Alkermes, Inc. Pulmonary delivery for levodopa
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7647931B2 (en) 2002-12-30 2010-01-19 Quiescence Medical, Inc. Stent for maintaining patency of a body region
WO2007005672A2 (en) * 2005-06-30 2007-01-11 The Scripps Research Institute Treatment and prevention of respiratory diseases and conditions
JP2007190278A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
JP2007190275A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
JP2007190277A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器および呼吸訓練プログラム
US20070233204A1 (en) * 2006-02-16 2007-10-04 Lima Marcelo G RFID-based apparatus, system, and method for therapeutic treatment of a patient
US7748493B2 (en) * 2006-06-14 2010-07-06 Zmed Technologies, Inc. Respiration stimulation
US7734350B2 (en) * 2006-06-14 2010-06-08 Zmed Technologies, Inc. Respiration apparatus
EP2037850A2 (en) 2006-07-06 2009-03-25 Quiescence Medical Inc Apparatus and methods for treating sleep apnea
US20100198103A1 (en) 2007-10-09 2010-08-05 Imthera Medical, Inc. System and method for neural stimulation
WO2009079078A1 (en) 2007-12-14 2009-06-25 Labogroup S.A.S. Delivering aerosolizable food products
US8428725B2 (en) 2008-10-09 2013-04-23 Imthera Medical, Inc. Method of stimulating a Hypoglossal nerve for controlling the position of a patient's tongue
AU2010318651A1 (en) 2009-11-10 2012-05-03 Imthera Medical, Inc. System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
WO2012025892A2 (en) * 2010-08-26 2012-03-01 Ben Gurion University Of The Negev Research And Development Authority Apparatus and method for diagnosing obstructive sleep apnea
WO2012082791A2 (en) 2010-12-13 2012-06-21 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US20120220531A1 (en) 2011-02-04 2012-08-30 Cincinnati Children's Hospital Medical Center Surfactant protein d for the treatment of disorders associated with lung injury
US10265013B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
US10265014B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
CN105010535A (zh) * 2015-07-30 2015-11-04 安徽人人福豆业有限公司 一种银耳豆渣发酵乳及其制备方法
CN105123926A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种疏肝理气豆渣发酵乳及其制备方法
CN105104535A (zh) * 2015-07-30 2015-12-02 安徽人人福豆业有限公司 一种养颜豆渣发酵乳及其制备方法
CN104982527A (zh) * 2015-07-30 2015-10-21 安徽人人福豆业有限公司 一种安神豆渣发酵乳及其制备方法
CN105053195A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种去火薄荷味豆渣发酵乳及其制备方法
CN104996566A (zh) * 2015-07-30 2015-10-28 安徽人人福豆业有限公司 一种清肺酒香豆渣发酵乳及其制备方法
CN105053191A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种消食木瓜豆渣发酵乳及其制备方法
CN105053194A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种清热通络豆渣发酵乳及其制备方法
CN105053196A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种风味草莓豆渣发酵乳及其制备方法
CN105123927A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种芦荟健胃豆渣发酵乳及其制备方法
CN105123928A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种润肠豆渣发酵乳及其制备方法
CN105053197A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种温中补血豆渣发酵乳及其制备方法
CN105053192A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种椰香补肾豆渣发酵乳及其制备方法
WO2019018338A1 (en) 2017-07-17 2019-01-24 Northriver Pharm, LLC NASAL COMPOSITION COMPRISING A MUCOADHESIVE POLYMER
CN111568853B (zh) * 2020-04-30 2023-07-28 杭州濡湜生物科技有限公司 一种新型肺部智能释药系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2520234A1 (fr) * 1982-01-28 1983-07-29 Gros Pierre Composition destinee a la prevention du ronflement
US4826821A (en) * 1985-06-26 1989-05-02 The Regents Of The University Of California Lung surfactant compositions
EP0273916A4 (en) * 1986-05-06 1989-11-30 Childrens Hosp Medical Center LUNG HYDROPHOBES, PROTEIN ASSOCIATED TO A SURFACE ACTIVE MEDIUM OF 6000 DALTON MOLECULAR WEIGHT AND MULTIMEREOUS ITEMS.
JPS63208524A (ja) * 1987-02-25 1988-08-30 Nippon Oil & Fats Co Ltd 睡眠リズム改善剤
US5238920A (en) * 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
DE69125750D1 (de) * 1990-05-21 1997-05-28 Abbott Lab Fettsäure-Oberflächenaktives-Lungenprotein Konjate
EP0635028B1 (en) * 1992-04-10 2003-01-22 Abbott Laboratories Pulmonary surfactant protein fragments
US5569679A (en) * 1994-12-30 1996-10-29 Russell A. Krueger Pharmaceuticals, Inc. Pharmacologic management of snoring
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US5925334A (en) * 1997-08-27 1999-07-20 Rubin; Bruce K. Use of surface active agents to promote mucus clearance

Also Published As

Publication number Publication date
NO994613D0 (no) 1999-09-23
NO994613L (no) 1999-10-28
IL132133A (en) 2008-12-29
HK1026141A1 (en) 2000-12-08
US5958902A (en) 1999-09-28
HUP0002645A2 (hu) 2001-06-28
ID29298A (id) 2001-08-16
KR100381643B1 (ko) 2003-04-26
WO1998046245A1 (en) 1998-10-22
AU722866B2 (en) 2000-08-10
CA2285574A1 (en) 1998-10-22
AR012221A1 (es) 2000-09-27
US6329352B1 (en) 2001-12-11
ATE298241T1 (de) 2005-07-15
TWI221771B (en) 2004-10-11
BR9809090A (pt) 2002-12-03
BG103800A (bg) 2000-03-31
AU6975598A (en) 1998-11-11
KR20010006384A (ko) 2001-01-26
NZ337969A (en) 2001-12-21
US20020099033A1 (en) 2002-07-25
CO4940399A1 (es) 2000-07-24
PL336326A1 (en) 2000-06-19
HUP0002645A3 (en) 2002-12-28
JP2001507364A (ja) 2001-06-05
DE69830660T2 (de) 2006-05-04
TR199902577T2 (xx) 2000-02-21
IL132133A0 (en) 2001-03-19
CN1252727A (zh) 2000-05-10
DE69830660D1 (de) 2005-07-28
EP1009411A4 (en) 2002-10-09
EP1009411B1 (en) 2005-06-22
CA2285574C (en) 2007-11-13
EP1009411A1 (en) 2000-06-21

Similar Documents

Publication Publication Date Title
SK143199A3 (en) Pharmaceutical composition for treating sleep apnea, lung alveolar surfactant, phospholipid, use thereof and device for treating sleep apnea
JP3830158B2 (ja) 禁煙補助組成物
Barach et al. Inhalation of penicillin aerosol in patients with bronchial asthma, chronic bronchitis, bronchiectasis and lung abscess: preliminary report
BG105889A (bg) Използване на ксенон за лечение на невроинтоксикации
US9861647B2 (en) Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
US5569679A (en) Pharmacologic management of snoring
US20030053956A1 (en) Alkylaryl polyether alcohol polymers for treatment and prophylaxis of snoring, sleep apnea, sudden infant death syndrome and for improvement of nasal breathing
JP4173538B2 (ja) 痛みの管理及び解毒のためのケタミンの点鼻及び点眼投与
CA2408633C (en) Management of snoring by oral administration of dimethyl sulfone
Tierney et al. Obstructive sleep apnoea
US20060210482A1 (en) Chemical composition and method for cold and sinus relief
CA2701388C (en) Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
CZ361199A3 (cs) Způsob a zařízení k léčbě spánkové apno
Berman et al. Sedation and analgesia
AU2002247032A1 (en) Alkyl aryl polyether alcohol polymers for improvement of nasal breathing